US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

73.84

+1.181.62%

Post-market: 72.79-1.0500-1.42%18:35 EDT

Volume:146.92K

Turnover:10.49M

Market Cap:16.98M

PE:- -

High:74.25

Open:71.71

Low:67.19

Close:72.66

52wk High:143.84

52wk Low:14.95

Shares:230.00K

Float Shares:230.00K

Volume Ratio:0.54

T/O Rate:63.88%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live

Moderately bullish activity in Moderna with shares down 1.79%

The Second Act of Biotech

Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/MRNX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":73.84,"timestamp":1789070400000,"preClose":72.66,"halted":0,"volume":146916,"hourTrading":{"tag":"盘后","latestPrice":72.79,"preClose":73.84,"latestTime":"18:35 EDT","volume":793,"amount":57755.715732000004,"timestamp":1789079736171,"change":-1.05,"changeRate":-0.01422,"amplitude":0.027627},"delay":0,"changeRate":0.016240022020368935,"floatShares":230000,"shares":230000,"eps":0,"marketStatus":"Post-Mkt","change":1.18,"latestTime":"09-10 19:02:07 EDT","open":71.71,"high":74.25,"low":67.19,"amount":10488746.073959999,"amplitude":0.097165,"askPrice":72.79,"askSize":10,"bidPrice":71.8,"bidSize":2,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":72.66,"sharesOutstanding":30000,"nav":78.06,"aum":17953800,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":71.68,"preClose":72.66,"latestTime":"09:29 EDT","volume":6434,"amount":464047.1028,"timestamp":1789046972693,"change":-0.98,"changeRate":-0.013487,"amplitude":0.066336},"postHourTrading":{"tag":"盘后","latestPrice":72.79,"preClose":73.84,"latestTime":"18:35 EDT","volume":793,"amount":57755.715732000004,"timestamp":1789079736171,"change":-1.05,"changeRate":-0.01422,"amplitude":0.027627},"volumeRatio":0.543512,"impliedVol":1.31,"impliedVolPercentile":0.0909},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":230000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.543512,"shares":230000,"dividePrice":0,"high":74.25,"amplitude":0.097165,"preClose":72.66,"low":67.19,"week52Low":14.95,"pbRate":"--","week52High":143.84,"institutionHeld":0,"latestPrice":73.84,"committee":-0.666667,"eps":0,"divideRate":0,"volume":146916,"delay":0,"ttmEps":0,"open":71.71,"prevYearClose":20.61,"prevWeekClose":84.15,"prevMonthClose":79.5,"prevQuarterClose":42.65,"fiveDayClose":90.85,"twentyDayClose":31.918,"sixtyDayClose":24.8167},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666311265","title":"Moderna Set for 3 Near-Term INT Data Readouts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311265","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311265?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:58","pubTimestamp":1788969505,"startTime":"0","endTime":"0","summary":"Moderna  is set for three data readouts on its individualized neoantigen therapies, or INT, in the near term, serving as potential stock catalysts for the company, UBS Securities said in a Tuesday note.The next major catalyst is the release of phase 3 data on melanoma at an international conference this fall, investors awaiting efficacy on recurrence-free survival and distant metastasis-free survival, the brokerage said.Likely to follow is the phase 2 data on either renal cell carcinoma or muscle-invasive bladder cancer, potentially in 2027, according to UBS. The next readout is probably a phase 3 update on adjuvant non-small cell lung cancer, the investment firm added.UBS has a neutral rating and $150 price target on Moderna.Price: 137.50, Change: -2.83, Percent Change: -2.02","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LGHT","BK4501","IDNA","BK4139","BK4588","BK4568","MRNA","BK4532","BK4548","BK4534","GNOM","WDNA","BK4551","BK4533","MRNY","MRNX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372326","title":"Moderately bullish activity in Moderna with shares down 1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:20","pubTimestamp":1788891611,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares down $2.60 near $142.95. Options volume relatively light with 44k contracts traded and c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-down-1-79-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-down-1-79-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNA","BK4585","BK4139","MRNX","MRNY","BK4534","BK4532","BK4568","BK4588","IDNA","WDNA","LGHT","GNOM","BK4501","BK4548","BK4551","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665531933","title":"The Second Act of Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2665531933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665531933?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:08","pubTimestamp":1788779310,"startTime":"0","endTime":"0","summary":"Pfizer sells dopamine. Moderna made the COVID vaccine. Both are betting their next decade on medicines that barely existed when their stocks peaked...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","GNOM","LU0321505868.SGD","LU1066051498.USD","LU0306807586.USD","LU1023059063.AUD","LU0456855351.SGD","PFE","BK4599","MRNX","LU2596442595.SGD","LU1883839398.USD","MRNY","BK4139","MRNA","WDNA","BK4532","LU0170899867.USD","LGHT","BK4533","LU0225771236.USD","SG9999013999.USD","BK4550","BK4585","SG9999002224.SGD","SG9999001176.SGD","LU0225284248.USD","OZEM","SG9999011175.SGD","IDNA","LU0985481810.HKD","BK4534","SG9999002232.USD","BK4551","IE00B3T34201.USD","SG9999003800.SGD","BK4501","BK4568","BK4588","BK4592","LU1057294990.SGD","LU1894683264.USD","LU0122379950.USD","BK4007","BK4548","LU0289739699.SGD","BK4581","IE000M9KFDE8.USD","SG9999001176.USD","LU0058720904.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU1066053197.SGD","LU0321505439.SGD","LU1894683348.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","IE0002270589.USD","LU0868494617.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162474456","title":"Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet","url":"https://stock-news.laohu8.com/highlight/detail?id=1162474456","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162474456?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:51","pubTimestamp":1788771108,"startTime":"0","endTime":"0","summary":"Hualan Biological Vaccine Inc. (301207.SZ) announced it has received the \"Drug Clinical Trial Approval Notice\" from the National Medical Products Administration for its novel influenza virus mRNA...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","MRNY","MRNX","BMED","301207","IBBJ","IBBQ","BK0239","MDTX","PSYK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MRNX\",params:#limit:6,delay:false,,,undefined,":[]}}